Variant report

Variant	esv3407004
Chromosome Location	chr12:1918741-1921239
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr12:1920868-1921315	HepG2	liver:	n/a	n/a
2	BHLHE40	chr12:1920726-1921486	HepG2	liver:	n/a	chr12:1921279-1921288 chr12:1921277-1921290 chr12:1921273-1921294 chr12:1921280-1921289 chr12:1921279-1921288
3	BHLHE40	chr12:1919741-1919978	K562	blood:	n/a	n/a
4	BHLHE40	chr12:1921026-1921446	K562	blood:	n/a	chr12:1921279-1921288 chr12:1921277-1921290 chr12:1921273-1921294 chr12:1921280-1921289 chr12:1921279-1921288
5	BHLHE40	chr12:1919012-1919508	K562	blood:	n/a	n/a
6	CTCF	chr12:1919988-1920012	GM19239	blood:	n/a	n/a
7	CTCF	chr12:1919961-1920006	NHEK	skin:	n/a	n/a
8	CUX1	chr12:1919339-1919506	K562	blood:	n/a	n/a
9	ELF1	chr12:1920818-1921125	HepG2	liver:	n/a	n/a
10	ELF1	chr12:1920758-1921139	HepG2	liver:	n/a	n/a
11	EP300	chr12:1920800-1921211	HepG2	liver:	n/a	n/a
12	EP300	chr12:1920794-1921249	HepG2	liver:	n/a	n/a
13	EP300	chr12:1920971-1921022	K562	blood:	n/a	n/a
14	EP300	chr12:1920969-1920974	HepG2	liver:	n/a	n/a
15	EP300	chr12:1919125-1919478	K562	blood:	n/a	chr12:1919275-1919285
16	FOS	chr12:1920847-1921211	HUVEC	blood vessel:	n/a	chr12:1921013-1921024
17	FOS	chr12:1919406-1919501	MCF10A-Er-Src	breast:	n/a	n/a
18	FOS	chr12:1919426-1919518	MCF10A-Er-Src	breast:	n/a	n/a
19	FOSL1	chr12:1919286-1919632	K562	blood:	n/a	n/a
20	FOSL2	chr12:1920715-1921279	HepG2	liver:	n/a	chr12:1920785-1920793
21	FOSL2	chr12:1919238-1919586	HepG2	liver:	n/a	n/a
22	FOSL2	chr12:1920673-1921412	HepG2	liver:	n/a	chr12:1920785-1920793
23	FOXA2	chr12:1919190-1919367	HepG2	liver:	n/a	n/a
24	GABPA	chr12:1920894-1921092	HepG2	liver:	n/a	n/a
25	HDAC2	chr12:1920767-1921337	HepG2	liver:	n/a	n/a
26	HEY1	chr12:1919353-1919716	HepG2	liver:	n/a	n/a
27	HEY1	chr12:1920604-1921363	HepG2	liver:	n/a	chr12:1920651-1920666
28	HNF4A	chr12:1920785-1921249	HepG2	liver:	n/a	chr12:1921024-1921036 chr12:1921019-1921041 chr12:1921023-1921038 chr12:1921024-1921037 chr12:1921022-1921037 chr12:1921024-1921036
29	HNF4A	chr12:1920411-1921160	HepG2	liver:	n/a	chr12:1921024-1921036 chr12:1921019-1921041 chr12:1921023-1921038 chr12:1921024-1921037 chr12:1921022-1921037 chr12:1921024-1921036
30	HNF4A	chr12:1920376-1921345	HepG2	liver:	n/a	chr12:1921024-1921036 chr12:1921019-1921041 chr12:1921023-1921038 chr12:1921024-1921037 chr12:1921022-1921037 chr12:1921024-1921036
31	HNF4G	chr12:1920819-1921167	HepG2	liver:	n/a	chr12:1921024-1921036 chr12:1921019-1921041 chr12:1921023-1921038 chr12:1921024-1921037 chr12:1921021-1921036 chr12:1921024-1921036
32	JUN	chr12:1918796-1919929	K562	blood:	n/a	n/a
33	JUN	chr12:1920951-1921082	HepG2	liver:	n/a	n/a
34	JUN	chr12:1919292-1919635	K562	blood:	n/a	n/a
35	JUND	chr12:1919313-1919513	HepG2	liver:	n/a	n/a
36	JUND	chr12:1919162-1919639	K562	blood:	n/a	n/a
37	JUND	chr12:1920810-1921139	HepG2	liver:	n/a	chr12:1921013-1921024
38	JUND	chr12:1920812-1921151	HepG2	liver:	n/a	chr12:1921013-1921024
39	JUND	chr12:1920799-1921239	HepG2	liver:	n/a	chr12:1921013-1921024
40	JUND	chr12:1920843-1921184	K562	blood:	n/a	chr12:1921013-1921024
41	MAFF	chr12:1920879-1921035	HepG2	liver:	n/a	n/a
42	MAFF	chr12:1919452-1919521	K562	blood:	n/a	n/a
43	MAFK	chr12:1919361-1919615	K562	blood:	n/a	n/a
44	MAX	chr12:1920839-1920851	HepG2	liver:	n/a	n/a
45	MAX	chr12:1919126-1921482	NB4	blood:	n/a	chr12:1921279-1921288 chr12:1921277-1921290 chr12:1921277-1921285 chr12:1921277-1921290 chr12:1921278-1921287 chr12:1921279-1921288 chr12:1921277-1921290 chr12:1919936-1919946 chr12:1921278-1921289
46	MAZ	chr12:1920721-1921300	IMR90	lung:	n/a	chr12:1921279-1921288 chr12:1921277-1921290 chr12:1921277-1921285 chr12:1921277-1921290 chr12:1921278-1921287 chr12:1921279-1921288 chr12:1921277-1921290 chr12:1921278-1921289
47	MAZ	chr12:1920873-1921233	HepG2	liver:	n/a	n/a
48	MAZ	chr12:1921011-1921117	K562	blood:	n/a	n/a
49	MAZ	chr12:1918954-1919582	K562	blood:	n/a	n/a
50	MYBL2	chr12:1920667-1921158	HepG2	liver:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr12:1921115-1921165	PrEC	prostate:	n/a
2	chr12:1921115-1921165	AG09309	skin:	n/a
3	chr12:1921115-1921165	Hela-S3	cervix:	n/a
4	chr12:1921115-1921165	HIPEpiC	eye:	n/a
5	chr12:1921115-1921165	MCF10A-Er-Src	breast:	n/a
6	chr12:1921115-1921165	HUVEC	blood vessel:	n/a
7	chr12:1921115-1921165	HRPEpiC	eye:	n/a
8	chr12:1921115-1921165	PFSK-1	brain:	n/a
9	chr12:1921115-1921165	ECC-1	luminal epithelium:	n/a
10	chr12:1921115-1921165	HMEC	breast:	n/a
11	chr12:1921115-1921165	T-47D	breast:	n/a
12	chr12:1921115-1921165	Jurkat	blood:	n/a
13	chr12:1921115-1921165	U87	brain:	n/a
14	chr12:1921115-1921165	NB4	blood:	n/a
15	chr12:1921115-1921165	HNPCEpiC	eye:	n/a
16	chr12:1921115-1921165	ovcar-3	ovarian:	n/a
17	chr12:1921115-1921165	HL-60	blood:	n/a
18	chr12:1921115-1921165	SK-N-SH_RA	brain:	n/a
19	chr12:1921115-1921165	AG04450	lung:	fetal
20	chr12:1921115-1921165	IMR90	lung:	fetal
21	chr12:1921115-1921165	CMK	blood:	n/a
22	chr12:1921115-1921165	Caco-2	colon:	n/a
23	chr12:1921115-1921165	HAEpiC	amniotic membrane:	n/a
24	chr12:1921115-1921165	HRCEpiC	kidney:	n/a
25	chr12:1921115-1921165	AG04449	skin:	fetal
26	chr12:1921115-1921165	GM12892	blood:	n/a
27	chr12:1921115-1921165	ProgFib	skin:	n/a
28	chr12:1921115-1921165	RPTEC	kidney:	n/a
29	chr12:1921115-1921165	A549	lung:	n/a
30	chr12:1921115-1921165	AG10803	skin:	n/a
31	chr12:1921115-1921165	MCF-7	breast:	n/a
32	chr12:1921115-1921165	HEEpiC	esophagus:	n/a
33	chr12:1921115-1921165	HCM	heart:	n/a
34	chr12:1921115-1921165	SK-N-MC	brain:	n/a
35	chr12:1921115-1921165	GM12878	blood:	n/a
36	chr12:1921115-1921165	SKMC	muscle:	n/a
37	chr12:1921115-1921165	K562	blood:	n/a
38	chr12:1921115-1921165	LNCaP	prostate:	n/a
39	chr12:1921115-1921165	GM19239	blood:	n/a
40	chr12:1921115-1921165	AoSMC	blood vessel:	n/a
41	chr12:1921115-1921165	HEK293	kidney:	embryo
42	chr12:1921115-1921165	H1-hESC	embryonic stem cell:	embryo
43	chr12:1921115-1921165	BE2_C	brain:	n/a
44	chr12:1921115-1921165	SK-N-SH	brain:	n/a
45	chr12:1921115-1921165	HPAEpiC	pulmonary alveolar:	n/a
46	chr12:1921115-1921165	NHBE	bronchial:	n/a
47	chr12:1921115-1921165	BJ	skin:	n/a
48	chr12:1921115-1921165	PANC-1	pancreas:	n/a
49	chr12:1921115-1921165	SAEC	small airway:	n/a
50	chr12:1921115-1921165	Hepatocyte	liver:	n/a

No.	Distal block	Cell Line	Cell type
1	chr12:1690585..1692934-chr12:1917638..1919676,2	K562	blood:
2	chr11:62647795..62648738-chr12:1919373..1920206,2	NB4	blood:
3	chr12:1912567..1914410-chr12:1917472..1919007,2	K562	blood:
4	chr12:1918012..1920353-chr12:1939627..1941633,2	MCF-7	breast:
5	chr12:1904001..1906826-chr12:1919472..1921344,2	K562	blood:

Variant related genes	Relation type
CACNA2D4	TF binding region
CACNA2D4	CpG island
ENSG00000151062	chromatin interactions
ENSG00000168003	chromatin interactions

Extended variants
information (count: 139 )
Associated
traits (count: 79 )

Variant overlapped rSNPs/rCNVs (count:139 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs574266880	chr12:1918771-1918772	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
2	rs192411683	chr12:1918841-1918842	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
3	rs140426573	chr12:1918847-1918848	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
4	rs533393559	chr12:1918854-1918855	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs184746980	chr12:1918864-1918865	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs374761320	chr12:1918883-1918884	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs532342178	chr12:1918897-1918898	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs188021626	chr12:1918906-1918907	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs567688301	chr12:1918909-1918910	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs193004808	chr12:1918940-1918941	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs150404092	chr12:1918948-1918949	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs571559019	chr12:1918965-1918966	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs138180346	chr12:1918967-1918968	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs550833409	chr12:1919023-1919024	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs151229065	chr12:1919053-1919054	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs35597913	chr12:1919063-1919064	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs553960824	chr12:1919109-1919110	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs184300542	chr12:1919110-1919111	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs573063701	chr12:1919150-1919151	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs536308321	chr12:1919164-1919165	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs554352977	chr12:1919176-1919177	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs529770039	chr12:1919179-1919180	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs149585666	chr12:1919248-1919249	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs146621214	chr12:1919297-1919298	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs556479017	chr12:1919304-1919305	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs577870888	chr12:1919329-1919330	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs139218988	chr12:1919331-1919332	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs560279372	chr12:1919332-1919333	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs527866892	chr12:1919339-1919340	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs543138702	chr12:1919351-1919352	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs561224550	chr12:1919354-1919355	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs377465576	chr12:1919355-1919356	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs550156732	chr12:1919418-1919419	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
34	rs189066664	chr12:1919448-1919449	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
35	rs372942250	chr12:1919451-1919452	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
36	rs376597404	chr12:1919452-1919453	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
37	rs368973969	chr12:1919476-1919477	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs374453274	chr12:1919486-1919487	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs571566788	chr12:1919529-1919530	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs2286377	chr12:1919543-1919544	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
41	rs371104619	chr12:1919546-1919547	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
42	rs373179862	chr12:1919552-1919553	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
43	rs2286376	chr12:1919553-1919554	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
44	rs181807410	chr12:1919556-1919557	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs147251076	chr12:1919636-1919637	ZNF genes & repeats Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs75775218	chr12:1919637-1919638	ZNF genes & repeats Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs374116777	chr12:1919656-1919657	ZNF genes & repeats Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
48	rs367703730	chr12:1919660-1919661	ZNF genes & repeats Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs368713272	chr12:1919695-1919696	ZNF genes & repeats Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
50	rs370241088	chr12:1919696-1919697	ZNF genes & repeats Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:79)

Disease	PMID	Source
Myelofibrosis	22110671	CNVD
Non-syndromic sensorineural hearing loss	19587683	CNVD
Glaucoma	21310917	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Malignant peripheral nerve sheath tumor	19844265	CNVD
Squamous cell cancer	19607727	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	17133270	CNVD
Esophageal squamous carcinoma	18405350	CNVD
Mental retardation	17847001	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
abnormal development	18461090	CNVD
Ovarian cancer	20844748	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Medulloblastoma	16968546	CNVD
Ovine squamous-cell carcinoma	17599052	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
Breast cancer	22032731	CNVD
Cancer	21183584	CNVD
Myxofibrosarcoma	16751306	CNVD
Non-small cell lung cancer	21829676	CNVD
Ovarian neoplasms	16753589	CNVD
Prostate cancer	21965145	CNVD
Acute myeloid leukemia	16864856	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Disorders of sex development	21048976	CNVD
Glioblastoma multiforme	21080181	CNVD
Liposarcoma	21253554	CNVD
Prostate cancer	19156837	CNVD
Emphysema	19352772	CNVD
Medulloblastoma	21979893	CNVD
Basal cell lymphoma	17053054	CNVD
Malignant germ cell tumour	17285132	CNVD
Melanoma	18172304	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Wilms tumour	21544195	CNVD
Squamous cell cancer	21044232	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	19960244	CNVD
Endometrial cancer	22040021	CNVD
Colorectal cancer	20709793	CNVD
Breast cancer	21264507	CNVD
Cancer	16751803	CNVD
Testicular cancer	18059402	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Seminomas	18059402	CNVD
Esophageal cancer	21851588	CNVD
Lung cancer	20668451	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Testicular germ cell tumor	18059402	CNVD
Malaria	21533027	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
Chronic lymphocytic leukemia	21670202	CNVD
Breast cancer	21364760	CNVD
Acute lymphoblastic leukemia	21248843	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Ewing''s sarcoma	17952124	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Breast cancer	21858162	CNVD
Breast cancer	21509527	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21785460	CNVD
Ovarian cancer	21720365	CNVD
Myelodysplastic syndrome	21251322	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Autism	22495311	CNVD
Lung cancer	18438408	CNVD
small cell lung cancer	20016488	CNVD
Cancer	20164919	CNVD
Urothelial carcinoma	21177765	CNVD

Chromatin state (count:138 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr12:1905600-1928600	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
2	chr12:1910800-1920000	Weak transcription	Primary B cells from cord blood	blood
3	chr12:1911600-1919200	Weak transcription	Osteobl	bone
4	chr12:1913800-1918800	Enhancers	Monocytes-CD14+_RO01746	blood
5	chr12:1913800-1920000	Enhancers	Fetal Thymus	thymus
6	chr12:1913800-1920400	Enhancers	Primary monocytes fromperipheralblood	blood
7	chr12:1914000-1920400	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
8	chr12:1914200-1919600	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
9	chr12:1914200-1919800	Weak transcription	Primary T cells from cord blood	blood
10	chr12:1914200-1920000	Weak transcription	Primary T regulatory cells fromperipheralblood	blood
11	chr12:1914200-1920600	Weak transcription	Primary T cells effector/memory enriched fromperipheralblood	blood
12	chr12:1914400-1918800	Weak transcription	Brain Germinal Matrix	brain
13	chr12:1914400-1919800	Weak transcription	Primary neutrophils fromperipheralblood	blood
14	chr12:1914400-1919800	Weak transcription	Primary T helper cells PMA-I stimulated	--
15	chr12:1914400-1920400	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
16	chr12:1915200-1919600	Weak transcription	Lung	lung
17	chr12:1915600-1920600	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
18	chr12:1916000-1919200	Weak transcription	Adipose Nuclei	Adipose
19	chr12:1916000-1919800	Weak transcription	NHDF-Ad	bronchial
20	chr12:1916000-1921200	Weak transcription	Primary T killer memory cells from peripheral blood	blood
21	chr12:1916000-1921600	Weak transcription	HSMM	muscle
22	chr12:1916600-1918800	Enhancers	HepG2	liver
23	chr12:1916800-1919000	Weak transcription	Fetal Muscle Leg	muscle
24	chr12:1917000-1919600	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
25	chr12:1917000-1919600	Weak transcription	Right Ventricle	heart
26	chr12:1917000-1919800	Weak transcription	Duodenum Mucosa	Duodenum
27	chr12:1917000-1920600	Weak transcription	Fetal Intestine Large	intestine
28	chr12:1917000-1923000	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
29	chr12:1917600-1918800	Weak transcription	Placenta	Placenta
30	chr12:1917600-1920200	Enhancers	Primary T cells fromperipheralblood	blood
31	chr12:1917600-1920800	Weak transcription	Fetal Intestine Small	intestine
32	chr12:1917800-1918800	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
33	chr12:1917800-1919600	Enhancers	Spleen	Spleen
34	chr12:1917800-1921400	Enhancers	Skeletal Muscle Female	skeletal muscle
35	chr12:1918000-1921200	Weak transcription	Primary T helper memory cells from peripheral blood 1	blood
36	chr12:1918200-1924000	Enhancers	Primary hematopoietic stem cells short term culture	blood
37	chr12:1918400-1918800	Enhancers	Primary T helper cells fromperipheralblood	blood
38	chr12:1918400-1919000	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
39	chr12:1918400-1919600	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
40	chr12:1918600-1920000	Enhancers	K562	blood
41	chr12:1918600-1920400	Weak transcription	Primary mononuclear cells fromperipheralblood	Blood
42	chr12:1918800-1919800	Enhancers	Placenta	Placenta
43	chr12:1918800-1920000	Weak transcription	Primary T helper cells fromperipheralblood	blood
44	chr12:1918800-1920400	Flanking Active TSS	HepG2	liver
45	chr12:1918800-1921200	Weak transcription	Primary T helper memory cells from peripheral blood 2	blood
46	chr12:1918800-1924000	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
47	chr12:1919000-1919600	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
48	chr12:1919200-1919400	Enhancers	Fetal Muscle Leg	muscle
49	chr12:1919200-1920000	Enhancers	Osteobl	bone
50	chr12:1919200-1921600	Enhancers	NH-A	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links